World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
68
Citations
15347
World Ranking
2175
National Ranking
93

Rob Schuurman publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Rob Schuurman sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 241 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Rob Schuurman D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Rob Schuurman sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 68 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Rob Schuurman is affiliated with Utrecht University in the Netherlands and has contributed extensively to the field of Medicine, with a particular focus on Epidemiology and Infectious Diseases. Their research covers several specialized subfields, including Surgery, Molecular Biology, and Microbiology.

The main topics addressed in Schuurman's work include:

  • Respiratory viral infections research
  • SARS-CoV-2 detection and testing
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Cervical Cancer and HPV Research
  • Hepatitis B Virus Studies
  • Pneumonia and Respiratory Infections

The scientist's recent publications illustrate a focus on viral diagnostics and epidemiology. Notable papers include:

  • "Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection" (2020), published in EClinicalMedicine
  • "Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study" (2021), published in The Lancet Regional Health - Europe
  • "Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure" (2020), published in Journal of Clinical Virology
  • "Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection" (2020), published in bioRxiv (Cold Spring Harbor Laboratory)
  • "Molecular Epidemiology and Evolutionary Trajectory of Emerging Echovirus 30, Europe" (2021), published in Emerging Infectious Diseases

Schuurman's collaborative network is comprised of several frequent co-authors, including:

  • Annemarie M. J. Wensing
  • Marc J. M. Bonten
  • L. Marije Hofstra
  • Willem J. G. Melchers
  • Hendrik Gremmels

The scientist's work has appeared repeatedly in several journals, reflecting their focused research presence. Key publication venues include:

  • Journal of Clinical Virology
  • EClinicalMedicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Medical Virology
  • Scientific Reports

Rob Schuurman's research, concentrated mainly on infectious diseases and diagnostic testing methodologies, intersects critical public health topics such as SARS-CoV-2 detection and HPV screening. The breadth of work across multiple journals and collaboration with other experts supports a diverse scientific output aligned with contemporary medical challenges.

Best Publications

  • Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR

    L. J. R. van Elden;M. Nijhuis;P. Schipper;R. Schuurman

  • Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)

    Rob Schuurman;Monique Nijhuis;Remko van Leeuwen;Pauline Schipper

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.

    Monique Nijhuis;Rob Schuurman;Dorien de Jong;John Erickson

  • High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase.

    C. A. B. Boucher;N. Cammack;P. Schipper;R. Schuurman

  • IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection

    Koenraad F. van der Sluijs;Leontine J. R. van Elden;Monique Nijhuis;Rob Schuurman

  • Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

    Roos E Barth;Maarten F Schim van der Loeff;Rob Schuurman;Andy I M Hoepelman

  • HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

    Raph L Hamers;Carole L Wallis;Cissy Kityo;Margaret Siwale

  • Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis.

    Jolanda D.F. De Groot-Mijnes;Aniki Rothova;Anton M. Van Loon;Margje Schuller

  • Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe

    Jurgen Vercauteren;Annemarie M. J. Wensing;David A. M. C. van de Vijver;Jan Albert

  • Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization

    Růžena Stránská;Rob Schuurman;Elske Nienhuis;Irma W. Goedegebuure

  • Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction.

    Leontine J.R. Van Elden;Anton M. Van Loon;Floris Van Alphen;Karin A.W. Hendriksen

  • Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.

    Rob Schuurman;Lisa Demeter;Patricia Reichelderfer;Jolanda Tijnagel

  • Effect of pretreatment HIV-1 drug resistance on immunological virological and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.

    Raph L. Hamers;Rob Schuurman;Kim C.E. Sigaloff;Carole L. Wallis

  • Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection.

    Jan Jelrik Oosterheert;Anton M van Loon;Rob Schuurman;Andy I M Hoepelman

  • Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection.

    Simon D. W. Frost;Monique Nijhuis;Rob Schuurman;Charles A. B. Boucher

  • Rapid and sensitive routine detection of all members of the genus enterovirus in different clinical specimens by real-time PCR

    Monique Nijhuis;Noortje van Maarseveen;Rob Schuurman;Sandra Verkuijlen

  • Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.

    Joep J. van Oosterhout;Neena Bodasing;Johnstone J. Kumwenda;Cooper Nyirenda

  • Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies

    Raph L. Hamers;Kim C. E. Sigaloff;Annemarie M. Wensing;Carole L. Wallis

  • Updated European recommendations for the clinical use of HIV drug resistance testing

    A. M. Vandamme;A. Sönnerborg;M. Ait-Khaled;J. Albert

  • Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring.

    Patricia W. H. Hugen;Nienke Langebeek;David M Burger;Bert Zomer

Frequent Co-Authors

Charles A. Boucher
Charles A. Boucher Erasmus University Rotterdam
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Anton M. van Loon
Anton M. van Loon Utrecht University
Kristel Van Laethem
Kristel Van Laethem Rega Institute for Medical Research
John W. A. Rossen
John W. A. Rossen University Medical Center Groningen
Tobias F. Rinke de Wit
Tobias F. Rinke de Wit University of Amsterdam
Annemarie M. J. Wensing
Annemarie M. J. Wensing Utrecht University
Clive Loveday
Clive Loveday University College London
Lidia Ruiz
Lidia Ruiz IrsiCaixa
Mika Salminen
Mika Salminen Finnish Institute for Health and Welfare

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can broaden career opportunities. Many institutions now offer online medical programs that provide flexible options for those pursuing healthcare or biomedical sciences. These programs are designed to accommodate various schedules, making them ideal for working professionals or those balancing other commitments.

Public health is another closely connected field, and finding which online MPH programs are easiest to get into can help students gain relevant skills quickly. A Master of Public Health degree complements microbiology knowledge by addressing disease prevention and epidemiology, expanding career pathways in health departments, nonprofits, and research institutions.

Career options extend beyond traditional roles; for example, a child life specialist supports pediatric patients and families through medical experiences, blending science with compassionate care — a meaningful choice for those drawn to healthcare environments.

Lastly, for individuals with challenging backgrounds, discovering the best degrees for felons can provide accessible and rewarding educational pathways, proving that higher education and career success in microbiology and related fields are achievable for all.

Best Scientists Citing Rob Schuurman

Trending Scientists

Recently Published Articles